FDA PMA FDA Class 3 Approved 🇺🇸 United States

Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)

PMA: P070008 · Supplement: S144 · Decision Jun 28, 2023
Classifications
1
FEI Numbers
25
Registration Numbers
25

Basic Information

Device Name
Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)
Trade Name
Pacemaker/ICD/CRT non-implanted components
PMA Number
P070008
Supplement Number
S144
Device Class
FDA Class 3
Product Code
NKE
Generic Name
Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P)
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
June 28, 2023
Date Received
December 19, 2022
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for the Amvia and Solvia family of pulse generators and cardiac resynchronization therapy pacekaer devices, as well as for updated programmer software versions PSW 2204.U and NEO 2204.U, updated Home Monitoring Service Center software version 3.55.0, and updates to the CardioMessenger Smart 4G firmware.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NKE Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)